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Abstract
Background: In the CNS, the heterotrimeric G protein Gαi2 is a minor Gα subunit with restricted
localization in the ventricular regions including the ependymal cilia. The localization of Gαi2 is
conserved in cilia of different tissues, suggesting a particular role in ciliary function. Although studies
with Gαi2-knockout mice have provided information on the role of this Gα subunit in peripheral
tissues, its role in the CNS is largely unknown. We used intracerebroventricular (icv) antisense
administration to clarify the physiological role of Gαi2 in the ventricular system.
Results:  High resolution MRI studies revealed that continuous icv-infusion of Gαi2-specific
antisense oligonucleotide caused unilateral ventricular dilatation that was restricted to the
antisense-receiving ventricle. Microscopic analysis demonstrated ependymal cell damage and loss
of ependymal cilia. Attenuation of Gαi2  in ependymal cells was confirmed by
immunohistochemistry. Ciliary beat frequency measurements on cultured ependymal cells
indicated that antisense administration resulted in ciliary stasis.
Conclusion: Our results establish that Gαi2 has an essential regulatory role in ciliary function and
CSF homeostasis.
Background
G protein-coupled receptors (GPCRs) communicate via
heterotrimeric G proteins which consist of α-, β- and γ-
subunits. According to the α-subunits, G proteins are
divided into four classes (Gs, Gi, Gq and G12). Half of all
known α-subunits belong to the Gi-family [1]. The need
for such a multiplicity of Gi family members is not imme-
diately evident. Proteins of the Gi family interact with a
wide variety of GPCRs, presently considered as important
drug targets.
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In the CNS, the concentrations of the Gi family subunits
Gαo and Gαi1 are extremely high, and their localization in
neuropil indicates involvement in neurotransmission or
some other crucial functions of neuronal cells [2,3]. In
contrast, Gαi2 has a highly restricted localization in the
ventricle-surrounding areas. In the rat brain, Gαi2 is local-
ized in the subventricular zone, the rostral migratory
stream [4], the accessory olfactory bulb [5] and the epend-
ymal cilia [6]. Such a specific localization implies that
Gαi2 may well subserve physiological function distinct
from those of the other Gα subunits. Moreover, Gαi2 is
also present in motile cilia which have a characteristic 9+2
ultrastructure in different peripheral tissues, such as rat
oviduct and trachea [6]. This may mean that the Gαi2 sub-
unit plays a specific, regulatory role in ciliary function.
These immunohistochemical findings were further sup-
ported by the proteomic analysis which revealed that Gαi2
is a resident axonemal protein of the human bronchial
cilia [7].
It is well known that Gαi2 can inhibit adenylyl cyclase
(AC) and thus decrease intracellular cAMP concentration
[8]. Further, in vitro studies with Gαi2-knockout mice have
provided information on the role of Gαi2 in peripheral tis-
sues, showing Gαi2 to mediate neurotransmitter-depend-
ent regulation of adenylyl cyclase in adipose tissue [9] and
Ca2+ channels in heart [10], as well as the signaling of the
ADP receptor P2Y12 in platelets [11]. Gαi2 has also been
implicated in the differentiation of hematopoietic cell
lines [12], as well as in insulin signaling in the periphery
[13]. Additionally, Gαi2-knockout studies in vivo have
reported defects in the immune response, growth retarda-
tion and ulcerative colitis leading to premature death
[14,15]. However, apart from a recent study providing evi-
dence that a pertussis toxin-sensitive G protein, assumed
to be Gαi2, is involved in neural stem cell proliferation in
the rat subventricular zone [16], we are not aware of any
reports elucidating the role of Gαi2 in the CNS.
In this study, we used in vivo antisense icv administration
to clarify the physiological role of Gαi2 in rat brain, espe-
cially in the ependymal cilia. Although the morphology of
the ciliated epithelium at the interface between the cere-
brospinal fluid (CSF) and the brain parenchyma has been
studied in detail [17-20], ependymal functions have
remained largely unexplored. The highly restricted ana-
tomical localization of Gαi2 in the ependymal cilia and
the subventricular areas [4,6] makes this subtype a partic-
ularly attractive target for specific and temporally control-
led knockdown by icv-delivered antisense-
oligodeoxynucleotides (AS-ODNs) without the fear for
development of compensatory mechanisms, which were
evident in previous studies with Gαi2 knockout mice [9].
Our data shows that knockdown of Gαi2 by specific anti-
sense oligonucleotide caused irreversible, unilateral ven-
tricular dilatation in rat in vivo, and ciliary stasis on
cultured rat ependymal cells in vitro. This suggests that
Gαi2 has an essential regulatory role in ciliary function
and CSF homeostasis.
Results
Icv administration of AS-ODN targeted against Gαi2 results 
in ipsilateral ventricular dilatation
We found that the rats receiving 7 days of icv AS-ODN
treatment developed unilateral ventricular dilatation that
was restricted to the AS-ODN-receiving lateral ventricle
(Figure 1). Since the intracranial pressure was not assessed
in this study, we call the condition ventricular dilatation
instead of hydrocephalus in this text. Neither saline nor
control oligodeoxynucleotides (ODN) infusion evoked a
similar effect. This outcome was highly reproducible and
it was evident both in young (3–5 weeks old, weighing
50–100 g), and in adult (250 g) animals. For the rest of
these in vivo studies, young animals were used. During the
7-day infusion and observation period, the animals grew
normally (Figure 2) and did not show any abnormal signs
except for dehydration, which was evident from day 2
onwards. No signs of colitis or immunological abnormal-
ities were observed. In order to evaluate the effects of AS-
ODN treatment on behavior, the animals were tested for
motor coordination, anxiety, motor activity as well as for
pain perception and morphine analgesia. No gross altera-
tions were observed (no significant behavioral differences
between the groups, results not shown).
Magnetic Resonance Imaging reveals the time-course for 
ventricular dilatation
The time-course of ventricular dilatation development
was examined by high resolution magnetic resonance
imaging (MRI) in vivo. The status of the ventricular system
in all animal groups was assessed by MRI both prior to
cannula implantation on day 0, and on days 2, 4, 7 of the
icv infusion (Figures 1, 3). Ventricular volumes (μl) and
wall surface areas (mm2) were calculated from consecu-
tive MRI images using the Cavalieri principle [21]. The
ipsilateral ventricles of AS-ODN treated rats dilated dra-
matically, reaching a plateau on day 4. The volume
increase of the ipsilateral ventricle was statistically signifi-
cant (p < 0.001) already on day 2, while the volumes of
contralateral, 3rd and 4th ventricles remained constant,
equal to that of day 0. Similarly, the surface area of the
ipsilateral ventricle wall enlarged greatly, being signifi-
cantly larger (p < 0.001) since day 2, while areas of con-
tralateral, 3rd and 4th ventricle showed no significant
changes in comparison to day 0. Animals in ODN and
saline control groups exhibited no changes, either in ven-
tricular volume or in ventricular wall surface area. Quan-
titative MRI data was used to create a three-dimensional
model of AS-ODN animals' ventricular system as it
appeared during the in vivo MRI study (Figure 3).BMC Neuroscience 2007, 8:26 http://www.biomedcentral.com/1471-2202/8/26
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To clarify whether the observed phenomenon was revers-
ible upon cessation of AS-ODN infusion, we studied the
time-response relationship of 2-day icv AS-ODN treat-
ment followed by a 9-day icv saline infusion. The dilata-
tion of the ventricles reached a new plateau level of
ventricular volume and wall surface area after the AS-
ODN treatment was stopped on day 2 (Figure 4). The new
plateau of volume was 28% lower, while the new plateau
of the wall surface area was 23% lower than that of con-
tinuous icv AS-ODN infusion. However, the time needed
to reach the new equilibrium (4 days) in ventricular vol-
ume was equal to that observed with continuous 7-day
AS-ODN icv infusion. Following the 2-day AS-ODN
administration, both the volume and the wall surface area
in the ipsilateral ventricle were significantly (p < 0.001)
larger than those of the contralateral ventricle since day 2.
These experiments indicate that the AS-ODN-evoked ven-
tricular dilatation was not reversible during the 11-day
observation period.
Ventricular volumes and wall surface areas imaged by high resolution MRI in vivo Figure 1
Ventricular volumes and wall surface areas imaged by high resolution MRI in vivo. Upper graph illustrates time-course of unilat-
eral ventricular dilatation in AS-ODN treated rats. The brain is shown from rostral side, i.e. the targeted right lateral ventricle 
is on the left. The level of coronal MRI images corresponds to ~Bregma -1.0. Graphs below show ventricular volumes (μl) and 
wall surface areas (mm2) in all treatment groups calculated from consecutive MRI images using the Cavalieri principle. Data 
represent mean ± SEM, (n = 4–10 animals in each time point). ***, p < 0.001 significantly different from the other ipsi- and con-
tralateral ventricles, one-way ANOVA with Tukey's Multiple Comparison test. AS-ODN, antisense-oligodeoxynucleotide 
against Gαi2; ODN control, mismatch-oligodeoxynucleotide.BMC Neuroscience 2007, 8:26 http://www.biomedcentral.com/1471-2202/8/26
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Histology and immunohistochemistry reveal ependymal 
cell damage and loss of Gαi2-immunoreactive ependymal 
cilia following AS-ODN treatment
The histological status of lateral ventricles was studied in
all animal groups by using hematoxylin-eosin staining.
The staining was done for 8 animals in each group, and
one representative specimen from each treatment group
was selected to visualize the general, light microscopic
view of the lateral ventricles (Figure 5). While the epend-
ymal cell layer of ODN and saline control groups showed
a normal, uniform ependymal cell row with numerous
cilia, the structure of the ipsilateral ependymal cell layer in
AS-ODN treated animals appeared damaged, irregular
and ruptured, with practically no cilia present. Addition-
ally, the ipsilateral ventricle of AS-ODN treated animals
showed numerous dying cell populations within the ven-
tricular cavity. Evidently, these cell populations originated
from the ependymal layer as a result of massive cell dam-
age, which followed the development of irreversible ven-
tricular dilatation and thus, stretching of the layer. In
contrast, contralateral ventricles in the AS-ODN treated
animals appeared normal, identical to the ventricles of
ODN and saline control animals.
The knockdown of Gαi2 protein in ependymal cells was
verified by immunohistochemistry using two different
primary antibodies. The first was a previously validated,
polyclonal affinity-purified reference antibody [22]. The
second was a commercial monoclonal antibody (Chemi-
con), which has not been previously validated for use in
immunohistochemistry. We verified the subunit specifi-
city of this antibody by Western blotting (Figure 6). Gαi2
immunolabeling in ependymal cells and cilia by the two
primary antibodies was imaged by confocal microscopy
(Figure 7). Both antibodies showed specific and restricted
labeling of Gαi2 in the ependymal cells and cilia while the
other brain areas were immunonegative. Despite minor
differences, the final outcome was the same with both
antibodies. AS-ODN treated animals showed loss of
ependymal cilia and attenuation of Gαi2 protein, whereas
Gαi2 immunostaining in ODN and saline control groups
was identical with both antibodies. While the polyclonal
antibody [22] interacted solely with ependymal cilia,
Chemicon's monoclonal antibody specifically recognized
cilia and also labeled structures surrounding ependymal
cell nucleus. The slight difference between the intracellu-
lar immunostaining with these antibodies could be due to
their different target regions in the Gαi2 protein and/or
due to potential cross-reactivity of the commercial anti-
body with additional targets, as evidenced by the presence
of additional immunoreactive bands (~45 and ~60 kDa)
in the Western blots of rat brain homogenates.
Western blot analysis shows no alterations in Gαi2 
immunoreactivity in more distal ventricular regions
To examine the extent of the AS-ODN effect, we deter-
mined Gαi2 levels by semi-quantitative Western blotting
of selected brain structures in close vicinity to the lateral
ventricles. The immunoreactivity of Gαi2 protein showed
no changes between AS-ODN treated and control animals
in motor cortex, striatum and choroid plexi (Figure 8).
A MRI based 3D image throughout the rat ventricular system Figure 3
A MRI based 3D image throughout the rat ventricular sys-
tem. The ventricles are viewed from caudal side, i.e. the tar-
geted right lateral ventricle is on the right. Great 
enlargement of the AS-ODN receiving right lateral ventricle 
is seen on day 7.
Growth curves of young (3–5 week old) animals during the  7-day infusion and observation period Figure 2
Growth curves of young (3–5 week old) animals during the 
7-day infusion and observation period. Arrow shows the age 
of surgery (24 days) and the starting point of the icv infusion. 
There were no significant differences between the treatment 
groups in one-way ANOVA with Tukey's Multiple Compari-
son test. Data are mean ± SEM (n = 5–23 animals in each 
group in each time point).BMC Neuroscience 2007, 8:26 http://www.biomedcentral.com/1471-2202/8/26
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Ciliary beat frequency measurements on cultured rat 
ependymal cells revealed ciliary stasis following AS-ODN 
treatment
To clarify the effect of AS-ODN on ependymal cells, we
carried out ciliary beat frequency (CBF) measurements on
cultured rat ependymal cells. AS-ODN administration
resulted in decreased CBF, leading to irreversible ciliary
stasis while the control oligo had no such effect (Figure 9).
In comparison to direct toxic effect on beating cilia,
namely the effect of positive control pneumolysin
[23,24], the effect observed after AS-ODN administration
emerged gradually, after a delay. Presumably, this delay
reflects the time needed for AS-ODN to enter the cells and
to terminate the synthesis of its target protein Gαi2. Statis-
tical analysis showed that CBF of AS-ODN treated cells
differed significantly (p < 0.001) from CBF in ODN and
saline control groups.
Morphology of cultured ependymal cells treated with AS-
ODN appeared normal at the timepoint when ciliary sta-
sis occurred. However, during the 48-hour observation
period the cells gradually started showing decreased via-
bility. In contrast, cells treated with pneumolysin typically
died immediately after exposure due to acute inflamma-
tion caused.
Discussion
In this study we used in vivo AS-ODN administration in an
effort to clarify the physiological role of Gαi2 in the rat
ventricular system. We found that continuous icv-infu-
Irreversible ventricular dilatation after 2-day AS-ODN infusion, imaged by high resolution MRI in vivo Figure 4
Irreversible ventricular dilatation after 2-day AS-ODN infusion, imaged by high resolution MRI in vivo. Left: the status of ven-
tricular system of AS-ODN treated rats on days 0, 2, 4, 7, 11. The brain is shown from rostral side, i.e. the targeted right lat-
eral ventricle is on the left. The level of coronal MRI images correspond to ~Bregma -1.0. Right: ventricular volumes (μl) and 
wall surface areas (mm2) calculated from consecutive MRI images using the Cavalieri principle. Data represent mean ± SEM (n 
= 4–5 animals in each time point). ***, p < 0.001 significantly different from the contralateral ventricle, one-way ANOVA with 
Tukey's Multiple Comparison test.BMC Neuroscience 2007, 8:26 http://www.biomedcentral.com/1471-2202/8/26
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sion of AS-ODN targeted against Gαi2 resulted in irrevers-
ible, unilateral ventricular dilatation that was restricted to
the AS-receiving ventricle. High resolution MRI revealed
that ventricular dilatation developed within 2 days and
that the ventricle further dilated until day 4. Microscopic
analysis revealed ependymal cell damage and loss of
ependymal cilia. Loss of Gαi2 in ependymal cells was dem-
onstrated by immunohistochemistry. CBF measurements
on cultured ependymal cells indicated that AS-ODN
administration resulted in ciliary stasis. Our results indi-
cate that Gαi2 has an essential and previously unrecog-
nized regulatory role in ciliary function and CSF
homeostasis.
We used young, 3–5 week old male rats but the ventricular
dilatation was seen after a 7-day icv AS-ODN treatment
also in adult animals. Gαi2 protein levels in rat brain have
been shown to be high already at birth, and to increase
slightly until the age of 90 days [25]. Additionally, previ-
ous studies have shown that the structure of the ependy-
mal layer reaches maturity by the age of 1–3 weeks, and
that cilia are fully developed by the first postnatal week in
mice and rabbits [17,19,26]. Thus, the use of young ani-
mals instead of adults was justified.
In order to avoid potential toxic effects due to the use of
stable, modified oligonucleotides, we chose to use
unmodified oligonucleotides which, however, are gener-
ally rapidly degraded by RNase H. In preliminary studies,
we administered a single icv injection of AS-ODNs with a
dose of 20 μg (in 4 μl/4 min), which, however, was with-
out any effect (results not shown). Evidently, CSF flow
constantly diluted the oligonucleotide concentration in
the lateral ventricle below the effective level, and thus,
continuous delivery (25 μg/day) was required to maintain
an effective concentration in the target area. Similarly, siR-
NAs have been reported to require continuous delivery to
achieve stable effects following icv administration in mice
[27].
We found that continuous icv AS-ODN infusion resulted
in unilateral ventricular dilatation that was restricted to
Typical light microscopic view of ipsilateral ventricles Figure 5
Typical light microscopic view of ipsilateral ventricles. Hematoxylin-eosin staining of coronal brain sections illustrates damaged, 
irregular and ruptured structure of the ependymal cell layer in AS-ODN (antisense-oligodeoxynucleotide against Gαi2) treated 
animals. Numerous dying cell populations float inside the ventricle and scarcely any cilia are present. The ependymal cell layer 
of ODN control (nonsense oligodeoxynucleotide) and saline control animals show a normal, uniform ependymal cell row with 
numerous cilia (arrowheads). Scale bar: upper images, 500 μm; lower images, 50 μm. cc: corpus callosum, S: septum, Str: stria-
tum.BMC Neuroscience 2007, 8:26 http://www.biomedcentral.com/1471-2202/8/26
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the AS-ODN receiving ventricle. A detailed analysis with
high resolution MRI revealed a supratentorially restricted
enlargement, without any signs of subarachnoidal
enlargement indicative of brain atrophy. There were no
signs of asymmetry attributable to obstruction in the ven-
tricular system, beyond the ipsilateral ventricle on MRI. In
AS-ODN treated animals, neither signs of peripheral
abnormalities, apart from dehydration, nor any behavio-
ral changes were observed.
In our study, AS-ODN penetration into adjacent neural
structures was not seen, as the immunoblotting of areas
distant from lateral ventricles, such as motor cortex and
striatum did not show any significant changes between
the animal groups. Due to targeting a one cell layer with
AS-ODN, immunoblotting was not an ideal method for
studying Gαi2 knockdown in ependymal cells. Not only
the quantity of these cells was very limited, especially for
the immunoblotting analysis of such a low-abundance
protein as Gαi2, but the severe damage of this cell layer in
AS-ODN treated animals made it impossible to derive suf-
ficient quantities of these cells for immunoblotting analy-
sis. The interpretation of the results would also have been
complicated, as the number of Gαi2 -rich cilia might have
varied between the samples. In order to reliably show
Gαi2 knockdown in each of the animals, we used immun-
ofluorescence on rat brain cryosections, which allowed us
to examine the endpoint status of individual ependymal
cells and the cilia in their native environment. Moreover,
this method was highly reproducible and enabled inspec-
tion of each of the animals after the treatment. While the
AS-ODN treated animals showed attenuation of Gαi2 pro-
tein and loss of cilia, ODN and saline control groups
showed identical, positive Gαi2  immunostaining of
ependymal ciliary membrane.
The connection between ciliary beat and CSF flow direc-
tion has been evident for decades [18,28]. A recent study
indicates further that beating of ependymal cilia is also
required for concentration gradient formation of CSF
guidance molecules directing proper migration of neurob-
lasts [29]. With respect to the link between cilia dysfunc-
tion and development of ventricular dilatation, it has
been clearly demonstrated that ciliary dysfunction results
in ventricular dilatation or hydrocephalus. Metavanadate,
an inhibitor of ciliary movement, has been shown to
induce hydrocephalus in rats [30]. Additionally, several
animal models of congenital hydrocephalus have been
reported, such as SUMS/NP mice [31] and WIC-Hyd rats
[32], the latter of which have been demonstrated to
exhibit immotile ependymal and respiratory cilia [33].
Both SUMS/NP and WIC-Hyd animals have a currently
unknown genetic defect.
Furthermore, several studies have shown that hydroceph-
alus results from deficiencies in cilia structure compo-
nents, such as the axonemal proteins Mdnah5 [34,35] or
Spag6 [36]. Similarly, hydrocephalus has been demon-
strated to follow deficiencies in proteins involved in cilio-
genesis, such as Polaris [37], HFH-4 [38] and polymerase
lambda [39]. Frequently, animals with cilia related genetic
defects have symptoms similar to those of Primary Ciliary
Dyskinesia (PCD) which occurs in humans. PCD is a con-
dition also including Kartagener's syndrome and immo-
tile cilia syndrome, and in addition to hydrocephalus,
PCD is characterized by many accompanying symptoms
such as sinopulmonary infections, situs inversus and
reduced fertility [40]. This is evidence of highly conserved
mechanisms in cilia motility in different tissues.
Several earlier studies have reported hydrocephalus fol-
lowing icv administration of viruses or bacteria [41,42].
Hydrocephalus related to local inflammation of motile
cilia might result from unspecific ciliary damage and dis-
ruption of ependymal cells. However, hydrocephalus can
also be induced by bacterial toxins or other inflammatory
mediators causing rapid ciliary stasis, as has been shown
for mycoplasma pulmonis [43]. There is the possibility that
inhibition of ependymal cilia [24] and loss of ependymal
Specificity of the commercial primary antibody verified by  Western blot Figure 6
Specificity of the commercial primary antibody verified by 
Western blot. Upper panel: A: G protein standard, (2 μl/
lane) Bovine brain immunoblot stardard, Calbiochem. B: Rat 
brain homogenate, (25 μg/lane). C: Rat brain homogenate, 
(35 μg/lane). D: Human platelet membrane (2 μg/lane). E: 
Molecular weight marker (MagicMark™, Invitrogen). Lower 
panel depicts β-actin, that was used as a loading control and 
was visualized after reprobing the membrane with mouse 
anti-β-actin antibody.BMC Neuroscience 2007, 8:26 http://www.biomedcentral.com/1471-2202/8/26
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cells [44] in pneumococcal meningitis may be directly
linked with post infection hydrocephalus that is com-
monly observed in patients after treatment [45].
In addition to our study, there is preliminary evidence
suggesting that inactivation of Gi family proteins results in
ventricular dilatation. Namely, mice with icv infection by
Bordetella pertussis seem to develop hydrocephalus, which
becomes apparent 4–6 days after the infection [46,47].
Evidently, in those early studies, hydrocephalus has devel-
oped following the inactivation of Gi family proteins by
pertussis toxin. Moreover, previous studies with cultured
hamster tracheal tissues have shown that Bordetella pertus-
sis infection results in ciliary stasis [48,49]. The facts that
pertussis toxin induces hydrocephalus following interac-
tion with the ependymal cilia, and causes whooping
cough following interaction with the respiratory cilia indi-
cate that the Gi family proteins play a fundamental role in
ciliary function. Given that Gαi2 is the predominant Gi
protein present in mammalian ependymal cilia, as well as
in motile cilia in different peripheral tissues, such as rat
oviduct and trachea [6,7], it may well have a ciliary-spe-
cific function. Consistent with this reasoning, we clearly
showed in this study, that the knockdown of Gαi2 follow-
ing AS-ODN treatment resulted in impaired ciliary func-
tion and resulted in unilateral ventricular dilatation in
vivo.
In our study, microscopic analyses revealed ependymal
cell damage and loss of ependymal cilia following attenu-
ation of Gαi2 by AS-ODN. This outcome is in line with
previous observations about ependymal injury and cell
damage resulting from hydrocephalus. Following either
acute or chronic hydrocephalus, the observed characteris-
tic ependymal changes are decreased cilia density as well
as a discontinuous, stretched and torn ependymal layer
[50-53]. In chronic hydrocephalus, also scar formation
has been reported [51]. It has been shown that irrespective
Gαi2 immunostaining imaged by confocal microscopy Figure 7
Gαi2 immunostaining imaged by confocal microscopy. Upper row, reference antibody against Gαi2 (Dr. Tomiko Asano); lower 
row, commercial antibody against Gαi2 (red) and Calbindin D-28 (green). Both antibodies show intense staining of ependymal 
cilia in ODN control (nonsense oligodeoxynucleotide) and saline control groups and attenuation of Gαi2 signal in AS-ODN 
(antisense-oligodeoxynucleotide against Gαi2) treated animals. Background staining with Calbindin D-28k (CaBP) was used to 
better visualize intracellular staining in endoplasmic reticulum with Chemicon antibody. Scale bar: 10 μm.BMC Neuroscience 2007, 8:26 http://www.biomedcentral.com/1471-2202/8/26
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of whether the hydrocephalus results from a virus, a
chemical agent or a genetic defect, the ependymal changes
following hydrocephalus are the same. Firstly, cilia, the
most vulnerable structure, are lost, then the microvilli dis-
appear [50], which presumably is due to extensive stretch-
ing of the ependymal layer [51]. Finally, the ependymal
cells are destroyed. However, it has been demonstrated
that normal cilia are present until hydrocephalus reaches
a comparatively late stage [50].
In this study, we also clarified whether the ventricular dil-
atation was reversible at the earliest point when it was evi-
dent (day 2) but found that the phenomenon was
irreversible. This outcome was expected, as it was known
that in mammals, ependymal cells do not regenerate at
any age [19,52]. This is largely based on the fact that pro-
liferation markers, such as Ki-67, has not been found in
the ependyma even in fetal life [54,55]. Although a regen-
erative response of subependymal cells following brain
trauma has been reported, the resulting regeneration does
not apply to the ependymal layer and furthermore, it may
be subsequently overwhelmed by severe degeneration
[56,57]. It is noteworthy that ciliary stasis in ependymal
cell culture was irreversible as well.
Although we showed that the ventricular dilatation
observed as an endpoint condition in our study could be
explained by ciliary stasis following AS-ODN treatment,
our study can not establish a causal link between the two
events in vivo. We cannot totally exclude the fact that cili-
ary immobility may not have been the only factor in the
development of ventricular dilatation. Although Gαi2
appears not to be particularly enriched in the choroid
plexus (our unpublished observations), knockdown of
Gαi2 in this tissue might also have contributed to the dis-
turbed CSF homeostasis and ventricular dilatation. This
reasoning is relevant in light of previous findings showing
that intracellular cAMP levels positively regulate CSF pro-
Western blot analysis of Gαi2 immunoreactivity in selected brain areas Figure 8
Western blot analysis of Gαi2 immunoreactivity in selected brain areas. Samples (diameter 1 mm) for immunoblotting were 
punched from 1 mm-thick brain slice as visualized in a coronal brain section. The samples of 9 animals in each group were 
pooled into three groups and processed in duplicate in Western blotting. Data represent mean ± SEM (n = 3). AS-ODN 
treated animals do not differ from control animal groups, one-way ANOVA with Tukey's Multiple Comparison test. Coronal 
unlabeled rat brain section (Bregma -0.26 mm) from Rat Brain Atlas [62].BMC Neuroscience 2007, 8:26 http://www.biomedcentral.com/1471-2202/8/26
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duction in the choroid plexus [58]. Besides this, a recent
study suggested that elevated activity of cAMP pathway
might be involved in development of hydrocephalus, as
elevated PKA and PKC activity was shown to result in cili-
ary defects and development of hydrocephalus in mice
overexpressing PAC1 receptor [59]. Further studies will be
required to rule out these and the other possible factors,
e.g. local inflammation, in the development of ventricular
dilatation following AS-ODN treatment.
Interestingly, dehydration, which was highly repeatable in
our study after 2 days of continuous icv AS-ODN infusion,
was also reported in a study with icv Bordetella pertussis
infection in mice [46]. Given the peculiar localization of
the circumventricular organs (CVOs) bordering the 3rd
and 4th ventricle, it seems possible that CSF might have a
role in their neuroendocrine regulatory functions [60]. It
is clear that AS-ODNs delivered intracerebroventricularly
can readily reach CVOs and thus, might easily interfere
with the signalling pathways regulating body fluid home-
ostasis. Previously, it was demonstrated that in vivo icv
administration of an AS-ODN targeted against the angi-
otensin AT1 receptor into 3rd ventricle resulted in thirst
attenuation in rats, indicating that icv AS-ODN treatment
can effectively reach CVO cells [61].
Conclusion
The aim of this study was to clarify the physiological role
of Gαi2 in the ependymal cilia by silencing its function by
in vivo icv antisense oligodeoxynucleotide (AS-ODN)
administration. Our results show that AS-ODN knock-
down of Gαi2 resulted in irreversible, unilateral ventricu-
lar dilatation in rat in vivo, and ciliary stasis on cultured rat
ependymal cells in vitro, raising the possibility that ciliary
stasis resulted in ventricular dilatation in vivo. Collectively
these findings indicate that Gαi2 has a hitherto unrecog-
nized physiological role in the regulation of ependymal
ciliary function and CSF homeostasis in the ventricular
cavity. To the best of our knowledge, this is a novel find-
ing and therefore may have immediate relevance to the
neuroscience community.
Methods
Animals
Three weeks old male Harlan Wistar rats (total n = 71 for
in vivo studies) were used in accordance with the Euro-
pean Communities Council Directive (86/609/EEC) and
following a protocol approved by the local ethics commit-
tee. Animals were bred in National Laboratory Animal
Center, University of Kuopio, and by National Public
Health Institute, Kuopio, and housed five per cage in 12-
h light/12-h dark cycle (lights on at 07:00 h) with food
and water ad libitum. In studies with adult animals, 250 g
weighing male Wistar rats were used. In ependymal cell
culture we used newborn Wistar rats (younger than 24 h),
bred by Biomedical Services, University of Leicester, UK.
Stereotaxic surgery
Animals were assigned in three groups (saline control, AS-
ODN and ODN control) and after three days of adapta-
tion to their home cages, at the age of 24 days, brain infu-
sion cannulas were placed in right lateral ventricles under
chloral hydrate (Merck, Darmstadt, Germany) anesthesia
(350 mg/kg i.p.) using stereotaxic surgery. Anatomical
structures were identified based on Rat Brain Atlas [62].
Cannulas were fixed in the skull with metal or nylon
screws (Plastics One, Roanoke, VA) and dental cement
(Voco, Cuxhaven, Germany). The Alzet minipumps
(Models 1007D and 2002, Durect, Cupertino, CA) were
sited subcutaneously dorsally. After cannula placement,
rats were housed one per cage to prevent damage of the
wounds and tubing. Animals received saline (n = 22),
antisense (n = 27), nonsense (n = 17) or mismatch (n = 5)
oligonucleotides (Sigma-Genosys, Haverhill, UK) as con-
tinuous icv infusion for 7 days (25 μg/day) starting from
surgery (days 24–31). Animals were examined and
weighed daily to ensure health and growth. The same pro-
cedures were used on adult rats (250 g, total n = 5).
Oligonucleotides
Sequences for unmodified 18-mer oligonucleotides were
chosen based on GenBank database search. The sequence
against Gαi2 did not match any other rat sequence except
for the N-terminal sequence of Gαi2 (nucleotides 150–
167). Selected nonsense and mismatch sequences did not
match any rat sequence. The following sequences were
used: anti-Gαi2: 5'-CTT GTC GAT CAT CTT AGA-3', non-
Ciliary beat frequency (CBF) measurements on cultured rat  ependymal cells Figure 9
Ciliary beat frequency (CBF) measurements on cultured rat 
ependymal cells. Ependymal CBF over time in the presence 
of AS-ODN against Gαi2 (122 μM) and ODN control (122 
μM, mismatch oligonucleotide), negative (aCSF) and positive 
(pneumolysin, 500 HU/ml) controls. The arrow indicates 
when the aCSF was exchanged for complete growth media. 
Data are mean ± SEM of n = 4–10. The AS-ODN (122 μM) 
and pneumolysin (500 HU/ml) graphs were significantly dif-
ferent (p < 0.001) compared to the controls, One-way 
ANOVA with Tukey's Multiple Comparison test.BMC Neuroscience 2007, 8:26 http://www.biomedcentral.com/1471-2202/8/26
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sense: 5'-GGG GGA AGT AGG TCT TGG-3', and mismatch
5'-TCT GCT GAT ACT CTT GAA-3' which was used as a
more stringent control, maintaining equal base composi-
tion to the antisense molecule but with eight mismatches.
The HPLC-purified (purity 90–97%) oligonucleotides
were dissolved in sterile saline. RNase free, aseptic condi-
tions were maintained until implantation of the cannulas
to prevent degradation of unmodified oligonucleotides
by RNase H prior to reaching the target cells.
Behavioral studies
On the 7th day of continuous icv infusion, animals (n = 8
per group) were tested for motor coordination, anxiety,
motor activity as well as for pain perception and mor-
phine analgesia. In rota-rod test, the ability of rats to stay
on revolving rod (2 rpm) was examined for 1 min. Ele-
vated plus maze measured anxiety and consisted of a plus-
shaped maze with two open and two enclosed arms. The
rats were individually placed into the maze for 3 min and
their movements and the time spent in all of the arms was
determined. Normally, rats prefer the enclosed arms but
show interest to enter also the open arms. Anxious ani-
mals tend to remain in the enclosed arms. The open field
test measured motor activity and consisted of a circular
maze with radial and circular lines marked on the floor.
The rats were individually placed into the maze and the
motor activity (line crossing) was observed for 2 min. In
the tail immersion test, the outermost 4 cm portion of the
rat tail tip was immersed in +53°C water bath 28 minutes
after s.c. morphine injection (10 mg/kg). The reaction
time of tail withdrawal was measured. The test was termi-
nated after 15 s if the rat gave no response to this slightly
painful stimulus.
Magnetic resonance imaging
To assess the status of the lateral, 3rd and 4th ventricles in
vivo, animals were examined by high resolution magnetic
resonance imaging (MRI). For this purpose, saline con-
trol, ODN control (mismatch oligonucleotide), and AS-
ODN groups were studied (n = 5 per group) before
implantation of infusion cannulas (day 0) as well as dur-
ing the infusion (days 2–7). Prior to MRI studies, rats were
anesthetized with chloral hydrate (350 mg/kg i.p.),
immobilized, and externally fixed to a custom-built ani-
mal holder. To maintain normal body temperature,
heated air was blown through the magnet bore during the
study. MRI was performed using A SMIS console (Surrey
Medical Imaging Systems, Guildford, UK) interfaced to a
9.4 T vertical magnet (Oxford Instruments, Oxford, UK).
A single loop surface coil (diameter 27 mm) was used in
transmit/receive mode. Multi-slice T2-weighted images
were acquired using a single-echo spin-echo method
(time-to-repetition 2000 ms, time-to-echo 40 ms, 4 aver-
ages/line, matrix size of 256 × 128 (zerofilled to 256 ×
256), field of view (25.6 mm × 25.6 mm) and 20 slices at
slice thickness of 0.7 mm). Brain ventricle volumes (μl)
and ventricle wall surface areas (mm2) were calculated
from consecutive images by the Cavalieri principle [21].
Animals were imaged immediately prior to implantation
of cannulas by stereotaxic surgery (day 0), followed by
MRI studies 2 (antisense rats only), 4, and 7 days later dur-
ing continuous icv infusion.
Histology
On the 7th day of continuous icv infusion, the rats (n = 8
per group) were decapitated and the whole brains were
dissected out, dipped in isopentane on dry ice and stored
at -80°C. Serial coronal 20 μm-sections were cut at -20°C
using a Reichert-Jung cryostat, approximately spanning
Bregma 1.2 mm to -1.8 mm [62]. Six coronal sections,
each from an individual animal and two from each treat-
ment group, were collected per slide and thaw-mounted
onto Super-Frost*/Plus slides (Menzel-Gläser, Braunsch-
weig, Germany) at 20°C. The sections were stored at -
80°C. Routine hematoxylin-eosin staining was used to
identify possible damage of the brain. For immunohisto-
chemistry, slides with brain sections were thawed by
immersion (10 min at 20°C) into fixative containing 4%
paraformaldehyde (TAAB, Berkshire, UK) and 0.05% glu-
taraldehyde (TAAB, Berkshire, UK) in 0.1 M phosphate
buffer (PB), pH 7.4. The slides were then washed for 2 × 5
min with 0.1 M phosphate buffered saline (PBS), the
excess buffer was removed and nonspecific binding was
blocked by 1.5% normal horse serum (NHS) for 15 min-
utes. Following removal of excess NHS, the slides were
incubated with the primary antibodies [Chemicon slides:
1:1000 Mouse anti-Gαi-2 monoclonal antibody,
MAB3077 (Chemicon International, Temecula, CA); and
1:1000 Rabbit anti-CaBP, CB 38 (Swant, Bellinzona, Swit-
zerland); Asano slides: 1 μg/ml Rabbit anti-Gαi2, a kind
gift from Dr. Tomiko Asano] or with 0.1 M PB, pH 7.4
(negative controls) overnight at 4°C. The slides were
washed with 0.1 M PB, pH 7.4 for 5 min and incubated
with secondary antibodies [Chemicon slides: 1:100 Bioti-
nylated horse anti-mouse (BA-2000, Vector Laboratories,
Peterborough, UK); and 1:300 Goat anti-rabbit Alexa
Fluor 488 (Molecular Probes, Eugene, OR); Asano slides:
1:2000 Goat anti-rabbit-Cy5 (Jackson ImmunoResearch,
West Grove, PA)] for 30 min at 20°C. The slides with
biotinylated secondary antibodies were then incubated
with 1:50 streptavidin Cy-5 (Jackson ImmunoResearch,
West Grove, PA) for 40 min at 20°C. Following antibody
incubations, all slides were washed for 2 × 5 min with 0.1
M PB, pH 7.4 and rinsed with water prior to coverslipping
with Gelmount (Biomeda, Foster City, CA). All the wash-
ing steps and the dilutions of the antibodies were carried
out in 0.1 M PB, pH 7.4. The immunofluorescent slides
were imaged using Nikon Eclipse-TE300 inverted micro-
scope, (Nikon Corporation, Japan) with Ultra VIEW laser
scanning confocal device (Perkin-Elmer, UK) using 60×BMC Neuroscience 2007, 8:26 http://www.biomedcentral.com/1471-2202/8/26
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objective. Images were further processed using Adobe
Photoshop (Adobe Systems, Mountain View, CA).
Western blotting
Within each treatment group (n = 9), the animals were
assigned in groups of three to pool tissues for Western
blotting. 1-mm coronal slice from frozen brains (Bregma
1.00 – 0.00 mm) were cut and two punches of 1 mm
diameter were taken from each slice from left and right
frontal motor cortex (mCtx) and striatum (Str). Rest of the
brain was thawed in ice-water bath and the choroid plexi
(ChP) were dissected out from both lateral ventricles.
Pooled tissues were sonicated in sonication buffer (1 mM
EDTA, 20 mM Tris-HCl pH 7.5) for 5 × 1 sec (mCtx, Str)
or for 10 × 1 sec (ChP) in an ice-water bath. The protein
content of the sonicates was measured using bicin-
choninic acid (BCA) protein assay by Pierce. Sonicates (35
μg protein/lane) were resolved in 10% SDS-PAGE and
blotted onto nitrocellulose membrane. Nonspecific bind-
ing was blocked by 5% non-fat dry milk in Tris-buffered
saline containing 0.05% of Tween 20 (TTBS). Blots were
incubated overnight in primary antibody [1: 500 Mouse
anti-Gαi-2 monoclonal antibody, MAB3077 (Chemicon
International, Temecula, CA)] in 2.5% non-fat dry milk in
TTBS at 4°C. After 4 × 10 min washes in TTBS the blots
were incubated in secondary antibody [1: 4000 Goat anti-
mouse IgG-HRP, SAB-100 (StressGen Biotechnologies,
San Diego, CA)] in 2.5% non-fat dry milk in TTBS for 1 h
at 20°C. Blots were washed 4 × 10 min with TTBS and the
chemiluminescent reaction was started with Western
Lightning chemiluminescent reagents (NEL104, NEL105,
Perkin-Elmer Life Sciences, Inc. Boston, MA) and the sig-
nal was detected on BioMax Light Film (Cat 1788207,
Kodak, Rochester, NY). To detect β-actin, the blots were
incubated in stripping buffer (in 100 mM β-mercaptoeth-
anol, 2% SDS and 62.5 mM Tris-HCl, pH 6.7) for 30 min
at + 50°C and non-specific binding was blocked by 5%
non-fat dry milk in TTBS. Blots were incubated overnight
in primary antibody [1: 1000 Mouse monoclonal anti-β-
actin, clone AC-15, ascites fluid A5441 (Sigma-Aldrich, St
Louis, MO)] in 0.2% BSA and 0.03% NaN3 in Tris-buff-
ered saline followed by 4 × 10 min washes in TTBS.
Finally, blots were incubated with secondary antibody [1:
20 000 Goat anti-mouse IgG-HRP, SAB-100 (StressGen
Biotechnologies, San Diego, CA)] in 2.5% non-fat dry
milk in TTBS for 1 h at 20°C. The pooled sonicates in all
treatment groups were processed as duplicates in Western
blot. Rat forebrain punch sonicate was used as an internal
standard. Rat brain homogenate and human platelet
membranes were used to verify the subunit specificity of
the primary antibodies in Western blotting. The films
were scanned using HP Precision Scan Pro and the band
densities were quantified in proportion to densities of β-
actin and internal standard bands by using Scion Image
software (Scion Corporation, Fredrick, MD).
Ependymal Cell Culture
Ependymal cells were grown using a method adapted
from Wiebel and colleagues [23,63]. Eight-well (25 × 35
mm) tissue culture trays were coated with bovine
fibronectin (75 μg/2 ml; ≅ 1 μg/cm2) and incubated at
37°C in 5% CO2 for 24 hours prior to use. New-born
(younger than 24 hours old) Wistar rats were killed by cer-
vical dislocation and their brains removed using careful
dissection. The cerebellum was removed, as was small (3
mm) edge regions of the frontal cortex and the left and
right cortical hemispheres. The remaining brain regions
(containing ependymal cells and progenitors) were
mechanically dissociated by passing the tissue through an
18-gauge needle in 2 ml of tissue culture medium. The
complete growth medium was serum-free Minimum
Essential Medium (Gibco Life Technologies, Paisley, Scot-
land) containing penicillin (100 IU/ml), streptomycin
(100 μg/ml), fungizone (2.5 μg/ml), bovine serum albu-
min (5 μg/ml), insulin (5 μg/ml), transferrin (10 μg/ml),
selenium (5 μg/ml) and from day 3 onwards thrombin
(0.5 IU/ml). Dissociated tissue from a single brain was
seeded (500 μl per well) into eight well (25 × 35 mm) tis-
sue culture trays, with each well containing 2 ml of
medium. The medium was replaced 3 days after seeding.
The adherent ependymal cells were fed by the replace-
ment of 2 ml of fresh medium two times a week. The cili-
ated ependymal cell colonies were identified at day 5 and
experiments were done using cells that were between 14–
28 days old, a time when cell proliferation was optimal.
Oligonucleotide addition
All experiments were performed in filter sterilised (0.2
μm, acrodisc) 1 ml of artifical cerebrospinal fluid [aCSF
(mM): NaCl (128), KCl (3), CaCl2(1.3), MgCl2  (1),
NaH2PO4 (22.3), D-Glucose (1.25) in deionised water pH
7.4 with 10 M NaOH]. Pneumolysin has previously been
shown to inhibit CBF in ependymal cultures [23], there-
fore it was used throughout as a positive control. Pneumo-
lysin was purified as previously described [64], made up
in aCSF at 500 Haemolytic Units (HU)/1 ml and used as
a positive control for inhibition of ependymal ciliary beat
frequency (CBF). Negative controls were incubated in 1
ml of aCSF alone. AS-ODN and ODN control oligonucle-
otides were mixed with 1 ml of aCSF at 122 μM then
added to the cells. The cells were incubated at (37°C) for
8 hours with CBF readings taken at 0, 1, 3, 6 and 8 hours.
At 8 hours the aCSF was exchanged for 1 ml of complete
growth medium and incubated at 37°C for 48 hours with
CBF readings taken at 24, 27, 30 and 48 hours.
Ciliary beat frequency
To determine ciliary beat frequency the cells were placed
in a humidified (70–90%) incubation (37°C) chamber
and observed using an inverted microscope system
(Diphot, Nikon, UK). Beating cilia were recorded using aBMC Neuroscience 2007, 8:26 http://www.biomedcentral.com/1471-2202/8/26
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digital high-speed video camera (Kodak Ektapro Motion
Analyser, Model 1012) at a rate of 400 frames per second,
using a shutter speed of 1 in 2000. The camera allows
video sequences to be recorded and played back at
reduced frame rates or frame by frame. Ciliary beat fre-
quency was determined by timing a given number of indi-
vidual cilia beat cycles. Basal ciliary beat frequency was
measured at 0 minutes, before addition of oligonucle-
otides or pneumolysin. Calculation of CBF (Hz): 400
(Number of frames per second)/5 (frames elapsed for 5
ciliary beat cycles) X 5 (conversion per beat cycle).
Data analysis
The MRI results are presented as mean ± SEM. CBF data
are presented as mean ± SEM of 12–30 individual CBF
measurements from 4–10 separate cell cultures. Mean
reading of each individual culture was obtained from 3
randomly chosen cilia. Statistical comparison was per-
formed by using one-way analysis of variance with
Tukey's multiple comparison test, analyzed with Graph-
Pad Prism for Windows (GraphPad Software, Inc., San
Diego, CA). Statistical significance was achieved when p <
0.05.
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